The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia

Published:2018-03 Issue: Volume:66 Page:1-7
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Zhao Huihui,Zhu Huayuan,Huang Jiayu,Zhu Yu,Hong Ming,Zhu Han,Zhang Jingjing,Li Shan,Yang Lijia,Lian Yun,Wang Shuai,Mao Jianping,Chen Yaoyu,Li Jianyong,Qian Sixuan

Funder

National Natural Science Foundation of the People’s Republic of China

National Public Health Grand Research Foundation

Priority Academic Program Development of Jiangsu Higher Education Institute

Key Project of Jiangsu province Health Agency

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference28 articles.

1. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia;Figueroa;Cancer Cell,2010

2. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia;Kantarjian;J. Clin. Oncol.,2012